Menu
Recruiting NCT07667114

Scapholunate Ligament Reconstruction Using Modified Flexor Carpi Radialis Tenodesis

— Observational Scapholunate Dissociation Scapholunate Ligament Rupture

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: modified flexor carpi radialis tenodesis.
Who it may be relevant to
Registry conditions: Scapholunate Dissociation, Scapholunate Ligament Rupture. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Germany
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Clinical Outcomes of Scapholunate Ligament Reconstruction Using Modified Flexor Carpi Radialis Tenodesis - A Retrospective Study From 2016-2026

Overview

Retrospective study of patients who underwent a modified flexor carpi radialis (FCR) tenodesis for scapholunate ligament injury at Waldfriede Hospital during the period 2016-2026. Primary outcome: Functionality of the operated wrist measured using the validated DASH questionnaire.

Interventions

  • Procedure modified flexor carpi radialis tenodesis
    Flexor carpi radialis (FCR) tenodesis for the reconstruction of the dorsal scapholunate (SL) ligament and the dorsal intercarpal ligament (DICL)

Primary outcome measures

  • DISABILITIES OF THE ARM, SHOULDER AND HAND (DASH) questionnaire [Time frame: At enrollment]

Eligibility criteria

Inclusion criteria

  • Age: ≥ 18 years
  • Capable of providing informed consent independently
  • Availability of written informed consent for the study

Exclusion criteria

  • Active malignant disease
  • Pregnancy at the time of the examination
  • Presence of SLAC arthritis
  • Lack of capacity to provide independent consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Germany · 1 center
  • Waldfriede Hospital — Berlin

Identifiers

NCT: NCT07667114 · BB 112/26

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗